Fig. 8From: MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancerSchematic of miR-181a-5p mediated regulation on STING. The upregulation of miR-181a-5p in olaparib-resistant cells increases STING degradation by targeting STING mRNA. Consequently, the STING downstream pathways is downregulatedBack to article page